[ad_1]
The Ministry of Health announced that the first batch of 1.7 million vaccines from the pharmaceutical company Pfizer will arrive in February that will help Colombia start its vaccination next February.
(See: European agency recommends approval of Pfizer vaccine against covid-19)
(Further: Colombia ends the week with a record of reported cases)
January will be a month of important preparations against the covid-19 vaccination, and February, the beginning of the vaccination, said Minister Fernando Ruiz when explaining the plan that has been prepared for 2021.
“In February we are going to have the first group of vaccines, which will be Pfizer’s, and there are 1.7 million biologicals. In January we will be working on the enlistment, the whole plan that must be done with the territorial entities to locate the sites and prepare the points where the vaccination will be done“, indicated the minister.
With this first batch and in accordance with the plan already designed, the first to vaccinate are the medical personnel “and we will continue with people over 80 years of age. In the second group are those from 60 to 79 years old and then people with comorbidities will come” Ruiz explained.
(Follow with: ‘Our silence generated anguish, but in the end I feel satisfaction’)
In February we will have the first group of vaccines that will be Pfizer’s and that are 1.7 million biological
This strategy will reduce mortality, since the first objective is to ensure that the people who have the highest risk of dying are the people who are initially vaccinated. Then comes a second stage in which it seeks to vaccinate the general population and in which the Military Forces, teachers and all the people who work in the care of other people are included, since these also represent a risk, said Ruiz .
(Read also: When can you get vaccinated? Know the phases and who will have priority)
“All this plan we seek to do in 2021 and as we already announced, we will not be vaccinating children under 16 years of age or pregnant women because the studies that exist on vaccines, they do not cover these populations, so there is not enough information to know the risk of these people “explained the head of the portfolio.
However, he added that in the course of next year more studies will possibly appear that will give greater certainty for these population groups.
HEALTH UNIT
